GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DE) » Definitions » Pretax Margin %

Melodiol Global Health (ASX:ME1DE) Pretax Margin % : -61.01% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Melodiol Global Health's Pre-Tax Income for the six months ended in Dec. 2023 was A$-7.28 Mil. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was A$11.93 Mil. Therefore, Melodiol Global Health's pretax margin for the quarter that ended in Dec. 2023 was -61.01%.

The historical rank and industry rank for Melodiol Global Health's Pretax Margin % or its related term are showing as below:

ASX:ME1DE' s Pretax Margin % Range Over the Past 10 Years
Min: -57300   Med: -870.16   Max: -187.74
Current: -187.74


ASX:ME1DE's Pretax Margin % is ranked worse than
88.82% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.12 vs ASX:ME1DE: -187.74

Melodiol Global Health Pretax Margin % Historical Data

The historical data trend for Melodiol Global Health's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Pretax Margin % Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial -423.06 -1,257.35 -482.97 -377.26 -187.74

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -347.16 -164.23 -587.60 -403.82 -61.01

Competitive Comparison of Melodiol Global Health's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Pretax Margin % falls into.



Melodiol Global Health Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Melodiol Global Health's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-35.523/18.921
=-187.74 %

Melodiol Global Health's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-7.276/11.926
=-61.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Melodiol Global Health  (ASX:ME1DE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Melodiol Global Health Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (ASX:ME1DE) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DE) Headlines

No Headlines